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The mechanisms of killing mediated by cytolytic lymphocytes have been exten-
sivelystudied in recentyears(1-10). Onekey cytolytic mediator, apore-formingprotein
(PFP; t also termed perforin, cytolysin, or C9-related protein) has been identified
both in CTL and NK cells. Perforin is released from the granules of cytotoxic lym-
phocytes onto target cell surfaces where it is thought to form transmembrane channel
lesions (6-10). Recent work from this and other laboratories has shown that cytolytic
lymphocytes, while killing their targets, do not undergo self-mediated lysis (11-15)
and that both CTL and NK cells also resist lysis by purified granules and perforin
(13-15). How lymphocytes protect themselves against the lytic effect of perforin is
currently unknown.
Perforin is related structurally, functionally, and antigenically to the terminal com-
ponents of the C cascade (16-19), which, like perforin, produce channel-like lesions
on target cell membranes when activated. Erythrocytes are generally resistant to
lysis mediated by C of the same species, a phenomenon known as homologous spe-
cies restriction (20-23). Homologous restriction is thought tobe mediated by a C8/C9-
related erythrocyte surface protein (C8-binding protein [C8BP] or homologous re-
striction factor [HRF]) (24-26). C8BP/HRF has likewise been suggested to mediate
protection oflymphocytes against lysis mediated by perforin (27, 28). Whereas these
studies have suggested that protection against C- and perforin-mediated lysis de-
pends on common mechanisms, the data presented here indicate that the two forms
of protection are distinct and may require different mechanisms/polypeptides.
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Materials and Methods
Animals.
￿
6-10-wk-old CD2F, mice were purchased from the Trudeau Institute (Saranac
Lake, NY). Male Sprague Dawley rats (ti400 g) were purchased from the Charles River
Breeding Laboratories, Inc., (Wilmington, MA).
Cell Lines.
￿
Murine CTL lines CTLL-R8 and CTLL-1 were maintained in aMEM (Gibco
Laboratories, Grand Island, NY) supplemented with 10% FCS and 10% IL-2-containing
leukocyte-conditioned medium . The target cell specificities of these lines have been reported
elsewhere (29). WEHI-164 (methylcholanthrene-induced murine fibrosarcoma), EL-4 (mouse
T cell lymphoma), and K562 (human erythromyloid leukemia cell line) were maintained
in culture in RPMI 1640 (Gibco Laboratories) supplemented with 5% FCS (RPMI/FCS).
Antibodies.
￿
Polyclonal anti-RBC antisera (goat anti-rabbit RBC, rabbit anti-mouse RBC)
and goat anti-mouse IgG Fc fragment antisera were purchased from Organon Teknika Corp.
(West Chester, PA). Polyclonal anti-asialo GMl and anti-laminin antisera were purchased
from Wako Chemicals (Dallas, TX) and from Biodesign Inc. (Kennebunkport, ME), respec-
tively. mAbs to human CD3 (OKT3, IgG2a) and to murine Thy-1.2 (TIB 99, IgM) were
produced in our laboratories from hybridomas obtained from American Type Culture Col-
lection (Rockville, MD). Antibodies to rat OX8, OX19, and OX39 were purchased from Ac-
curate Chemical & Scientific Corp. (Westbury, NY). Production and characterization of the
anti-CD16 antibody B73.1 (IgGI) has been described previously (30). FITC-labeled goat
F(ab)'2 fragments directed against IgG H and L chains were used for indirect im-
munofluorescence and were purchased from Tago Inc. (Burlingame, CA).
A polyclonal antiserum specific for murine CTLL-R8 cells was prepared in rabbits im-
munized subcutaneously with 3 x 107 live CTLL-R8 cells suspended in PBS, and given five
boosts, one every 3 wk. Serum was collected 5 d after each boost. This antiserum reacts with
>95% of R8 cells as analyzed in a FAGS (Becton Dickinson & Co., Mountain View, CA)
and was used at 1 :40 dilution.
Complements.
￿
The sera used as source of C were from guinea pig, rabbit, and mouse
(CD2F,). Sera from more than one animal were rapidly processed and pooled.
RBCs.
￿
RBC of goat, cow, sheep, swine, rabbit, rat, chicken, and goose were purchased
from Carolina Biological Supply Co., (Burlington, NC). All RBC preparations were main-
tained in sterile Alsever's solution (Gibco Laboratories) at 4°C and used before the expira-
tion date. Fresh mouse and human RBC were collected, stored in Alsever's solution at 4°C,
and used within 2 wk.
Murine Thymocytes.
￿
Thymuses were removed aseptically from CD2F, mice. Single cell sus-
pensions were prepared by mincing with the hub ofa syringe in RPMI 1640. The cell suspen-
sions were passed through 100-gauge steel mesh, washed three times in RPMI 1640, and
resuspended in the same medium.
Rat andHuman LAK/NK Cells.
￿
Rat LAK cells were prepared according to a procedure
modified from a published protocol (31). Rat spleens were aseptically removed and single
cell suspensions were prepared in RPMI 1640. Contaminating RBC were lysed with NH4Cl
(0.88%) solution, followed by two washes in serum-free RPMI 1640 medium. After passage
through a nylon wool column, the nonadherent cells were cultured in RPMI 1640/FCS medium
containing 1,000 U/ml rIL-2 (generously supplied by Cetus Corp., Emeryville, CA). After
a 2-d incubation the culture plates were washed with RPMI 1640 containing 2 170 FCS, and
the adherent cells were incubated with rIL-2-containing medium for an additional 2 d. On
day 4, typically, >95% of the cells were positive for the NK markers OX8, asialo GMl, and
laminin, and <8% of them were positive for the T cell markers OX19 and OX39, as deter-
mined by FACS analysis.
Human lymphokine-activated killer (LAK) cells were prepared according to a published
protocol (32, 33) with minor modifications. Briefly, human PBMC were isolated by Ficoll-
Hypaque (Pharmacia Fine Chemicals, Uppsala, Sweden) gradient centrifugation from
plateletpheresis leukocyte concentrates obtained from the New York Blood Center, New York.
PBMC were depleted of monocytes and B lymphocytes by adherence to plastic dishes and
to nylon wool columns, respectively (34). Plastic- and nylon wool-nonadherent lymphocytes
were washed and resuspended in RPMI 1640/FCS. A negative selection procedure (panning
with anti-CD3 OKT3 antibodies) was used to enrich for NK cells (35). Briefly, cells wereJIANG ET AL.
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incubated with OKT3 hybridoma supernatant (at 1 :3 dilution) for 1 h at 4°C, washed, and
resuspended (3 x 106 cells/ml) in RPMI 1640/FCS. Washed cells were then plated in petri
dishes previously coated with goat anti-murine IgG (120 ug IgG per 60 x 15-mm dish). Plates
were then centrifuged at 40 g for 4 min and incubated at 40C for 60 min, after which, the
nonadherent cells were collected and washed three times with serum-free RPMI 1640. This
procedure yielded a cell population enriched for cells with NK cell phenotype, with 95%
ofcells staining positive for the NK cell marker B73 .1, as determined by FACS analysis. Cells
were resuspended (2 x 106 cells/ml) in RPMI 1640, supplemented with 10% FCS, 2 mM
glutamine, 5 x 10 -5 M 2-ME (Sigma Chemical Co., St. Louis, MO), penicillin (50 U/ml),
and streptomycin (50 ug/ml). Human rIL-2 was added to a concentration of 1,000 U/ml.
After 4 d of incubation at 37 0C in 5% C02, cells were harvested and used as LAK cells.
In some experiments, large numbers of homogeneous human NK cell populations were
purified from short-term cultures of PBMC with B lymphoblastoid cell line RPMI 8866 as
described (36, 37). Briefly, PBMC from healthy donors were cultured with 30 Gy-irradiated
RPMI 8866 cells. The cells were collected on day 9, and homogeneous preparations of
CD16'/NKH1'/CD3- /CD5- NK cells were negatively selected and purified by density gra-
dient centrifugation aftersensitization of the lymphocytes with a mixture of anti-CD3 (OKT3),
anti-CD5 (B36.1), and anti-monocyte (B52.1) mAbs, and indirect rosetting with CrCls-
treated goat anti-mouse Ig-coated erythrocytes (36). The purity of NK cells, as tested by
indirect immunoflubrescence with a panel of anti-NK and anti-T mAbs, always exceeded
95%. The purified NK cells were kept in culture (106 cells/ml) with rIL-2 (100 U/ml) for 4
d. The cells were then collected; washed three times with PBS, and kept frozen as a pellet
at -70'C until used to prepare extracts enriched for PFP/perforin.
Preparation of Cell Extracts.Enrichedfor Perforin from Human and Rat LAK/NK Cells.
￿
IL-2-
activated human NK cells were resuspended (2 x 10'/ml) in relaxation buffer (130 mM KCI,
5 mM NaCl, 1 mM disodium ATP, 2 MM MgC12, 10 mM Hepes, 1 mM EGTA, and 1 mM
PMSF, pH 6.8) and disrupted by nitrogen cavitation, as previously described (29). After
centrifugation at 800 g for 10 min, the pellet, containing hemolytic activity, was resuspended
in PBS (2 x 108 cell equivalents/ml) and subjected to three cycles of freezing and thawing.
After sedimentation of debris in a microfuge for 5 min, the supernatant, containing all the
hemolytic and cytolytic activity, was collected. This material was stored frozen (-20°C) until
used as a source of perforin-containing extract from human NK cells.
Perforin-containing extracts from rat LAK/NK cells were prepared by directly resuspending
cellsin PBS (2 x 107 cells/ml) followed by three cycles of freezing and thawing. The nucleus-
free supernatant aftera 5-min centrifugation in a microfuge was collected and kept at - 20'C
until use. A granule-enriched material from CTLL-R8 cells (29) was used as source ofmouse
perforin.
Purification ofMurine Perforin.
￿
Murine perforin was purified from CTLL-R8 cells, following
modifications made on a previously published protocol (29, 38). Briefly, nucleus-free lysates
of R8 cells (5-10 x 109) were centrifuged at 39,000 g for 20 min. The organelle-enriched
pellets were resuspended in relaxation buffer (108 cell equivalents/ml) to which the same
volumes of 2 x extraction buffer (4 M NaKHP04, pH 6.5, 1 mM EGTA, 0.2 mM di-
isopropyl fluorophosphate [Sigma Chemical Co.]) were added and the mixtures were incubated
on ice for 1 h. After centrifugation at 39,000 g for 30 min, the upper fluffy liquid phases
containing most of the hemolytic activity were collected and resuspended in 400 mM NaCI/20
mM Tris-HCI, pH 8. After another centrifugation (39,000 g, 30 min), the PFP-enriched su-
pernatant was diluted fivefold in buffer A (20 mM Tris HCl, 1 mM EGTA, pH 7.2) and
subjected to ion-exchange chromatography using an FPLC system (Pharmacies Fine Chem-
icals). The starting material was first applied to a DEAE-Sepharose column equilibrated with
buffer A and eluted with a 0.1-1 M NaCl linear gradient (in 150 min) at 3 ml/min. The frac-
tions containing hemolytic activity were pooled, diluted 10-fold in buffer A, loaded on a Mono
Qcolumn, and eluted at 0.5 ml/min (gradient, 0.1-1 M NaCl in 45 min). The active fractions
from the Mono Q, column were further fractionated on a Superose 12 column, equilibrated,
and eluted with 300 mM NaCl, 20 mM Tris-HCI, pH 7.2, and 1 mM EGTA at 0.3 ml/min.
Active fractions were pooled and used as a source of purified perforin. Purification of-1,000-
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migrating with M, of 70,000 could be visualized by staining with silver nitrate. Since the
hemolytic activity of perforin is labile and has a short half-life (29), this purification fold
probably represents an underestimate of the actual extent o£ purification achieved.
Complement-mediatedHemolysis.
￿
Mouse and rabbit RBC were washed and resuspended (5 x
108/ml) in dextrose/gelatin-containing veronal buffer (DGVB2, ) (Diamedix Corp., Miami,
FL) as described (39). Mouse or rabbit RBC suspension was mixed (1 :1, vol/vol) with rabbit
anti-mouse RBC antiserum diluted 1:200 in gelatin-containing veronal (GVB24 ) with 10
mM EDTA (Diamedix Corp.) or with goat anti-rabbit RBC antiserum diluted 1 :20, respec-
tively. The cell mixtures were incubated on ice for 30 min, after which cells were washed
three times and resuspended (5 x 108/ml) in GVB2` . Sera from mice, rabbits, and guinea
pigs were diluted 1 :10, 1 :20, and 1 :40, respectively, in GVB2` . 150 ul of diluted sera were
added in triplicates to a 96-well plate, followed by addition of 20 wl of a suspension ofantibody-
coated mouse or rabbit RBC. After shaking on a plate minishaker (Dynatech Laboratories,
Inc., Alexandria, VA) for 1 min, the plate was incubated at 37°C for 60 min, after which
it was centrifuged at 200 g for 10 min. 50 wl of the cell-free supernatant from each well was
transferred to a new plate. Release of hemoglobin was determined spectrophotometrically
at 410 nm using an automated microplate reader (model MR700; Dynatech Laboratories,
Inc.). Hemolysis was calculated according to the formula: percent hemolysis = 100 x (OD4,{}
experimental release - OD410 spontaneous release)/(OD4,o total release - OD4io sponta-
neous release). Spontaneous or total release ofhemoglobulin was determined in wells in which
RBC suspension was incubated with 150 wl of GVB2* or water, respectively.
Perform-mediatedHemolysis.
￿
Purified perforin or perforin-containing extracts diluted in PBS
were added, 140 ul per well in triplicates, to 96-well plates; 20 PI of RBC suspension (5 x
108/ml PBS) and 10 gl of 20 mM CaC12 solution were then added sequentially. The plates
were shaken for 1 min and incubated at 37°C for 30 min. Hemolysis was measured as de-
scribed above. The titer of each perforin preparation used in these assays was determined
before the test: one hemolytic unit (HU) of PFP was defined as the amount of material re-
quired to achieve 50% hemolysis of 107 murine RBC in a volume of 170 pl during a 30-min
incubation at 37°C. Because perforin activity is labile, there is usually a slight change in
the final hemolytic activities when experiments are performed after HU ofperforin activity
have been determined. In most experiments, therefore, one predetermined HU of perforin
does not lead to exactly 50°fo hemolysis of murine RBC, as would be expected otherwise.
To ensure validity of all analyses, experiments in which the activities ofboth C and perforin
were compared were all performed simultaneously, using the same batches of lytic reagents
and cells.
C- and Perform-mediated Cytolysis of Nucleated Cells.
￿
Nucleated cell targets were washed 3
times with RPMI 1640 and resuspended (8 x 106 cells/ml) in 0.25 ml FCS containing 0.05
mci of Na25'CrO4 (New England Nuclear, Boston, MA). After a 60-min incubation at 37°C
with occasional shaking, cells were washed three times, resuspended in serum-free RPMI
1640, and stored on ice until use.
For C-mediated lysis, the "Cr-labeled cells were resuspended in RPMI 1640 containing
specific antibodies at the indicated dilutions and incubated on ice for 30 min, after which
the cells were washed three times and resuspended in RPMI 1640 to 105 cells/ml for cell lines
and 2 x 105 cells/ml for primary cells. 100 gl of cell suspension was added in triplicates to
round-bottomed microtiter wells and mixed with 40 wl of C-containing fresh sera diluted
1:10, 1 :20, or 1 :40 in RPMI 1640. After a 60 min incubation at 37°C, 70 Al of the superna-
tant in each well was collected for determination ofradioactivity. The percent of specific "Cr
release was determined as described (13).
In experiments using perforin-containing material, the indicated amount of perforin in
40 wl of RPMI 1640 (without CaC12) was mixed with 100 ul of "Cr-labeled target cells in
a microtiter well in triplicates and incubated at 37°C for 3 h, after which the "Cr release
was measured as before.
Results
Homologous Species Restriction Associated with C and Perforin.
￿
Most studies describing
the phenomenon of homologous species restriction were performed using the reac-'an
0
E
u
x
tive lysis method, that is, by incubating RBC with defined quantities of purified
C5b-6, C7, C8, and C9; this phenomenon, however, can also be easily visualized
treating antibody-coated RBC with fresh sera as sources of C. In the experiment
shown in Fig. 1 A, rabbit, guinea pig, and mouse C-mediated lysis was tested using
mouse RBC sensitized with rabbit anti-mouse RBC antibodies. Rabbit and guinea
pig, but not mouse, sera readily induced hemolysis. Conversely, rabbit RBC coated
with goat anti-rabbit antibodies were efficiently lysed by mouse and guinea pig sera
but poorly by rabbit sera (Fig. 1 B) . These complementary results indicate that all
sources of C used in our experiments were active, and furthermore, that the resis-
tance of RBC to C-mediated lysis is independent of the source of antibody (goat
vs. rabbit).
We next tested whether homologous species restriction was also applicable to
PFP/perforin of lymphocytes. Perforin purified from mouse CTLL-R8 was tested
against RBC from 10 different species (Fig. 2). RBC from all 10 species tested (cow,
goat, sheep, swine, goose, chicken, rabbit, rat, mouse, and man) were susceptible
to mouse perforin-mediated lysis, though at different degree. Similar results were
obtained using partially purified granule-enriched material from CTLL-R8 (data
not shown), consistent with the earlier observations that the hemolytic activities as-
sociated with cytolytic lymphocytes can be accounted for entirely by perforin. Sev-
eral different batches of RBC and perforin yielded similar results. Although RBC
from the different species were somewhat variable in their sensitivity to perforin-
mediated lysis, no clear pattern of restriction could be observed, and the absolute
JIANG ET AL.
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FIGURE 1.
￿
Hemolysis of rabbit and
murine RBCby homologous andhet-
erogous C.Antibody-coated mouse(A)
and rabbit (B) RBC were incubated
with the indicateddilutions of guinea
pig (O), rabbit ("), and mouse (A)
sera at 37oC for 1 h. Hemolysis was
determined as described in Materials
andMethods. Mouseandrabbit RBC
were coated with rabbit anti-mouse
RBC antisera and goat anti-rabbit
D 110
1 :20
￿
1 :10
￿
antisera, respectively.
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" Man
FIGURE 2. Hemolysis mediated by
purified PFP/perforin. RBC from the
10 indicated species were incubated
with purified murine PFP/perforin in
the presence of 1 mM CaC12 at 37oC
for30 min. ThePFPHU were defined
using mouse RBC as targets (see
Materials and Methods).2212 IC LYMPHOCYTES RESIST PERFORIN-MEDIATED K
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from these cell types lysed both homologous and heterologous RBC (Figs . 4 and
5) . However, some differences in target cell susceptibility were noted when rat and
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lysed only 6% of swineRBC and none
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and Methods) .
C- and Per, orin-mediated Lysis ofNonerythroid Nucleated Target Cells.
￿
All the
observations on homologous species restriction have been obtainedwith RBC (20-23).
Fig . 6shows results from an experiment indicating that the samephenomenon
with nucleated targets . C-dependent lysis mediated by sera from different species
was tested on EL-4, a marine T lymphoma cell line bearing Thy-1.2 antigen (40),
PFD (HU)
perform. rerforin tro
ouse performlysed significant
-containing extract
goat, and sheep RBC (Fig . 4), and
detected with IHU ofhuman
ed usingmouse
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*coot
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wRot
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NG
RBC as tar
MaterialsandMethods) . Data were
polated from Fig, 2 . TheHU far 5t)%
hemolysis of marine RBC is not exactly
1, asexpected, mainly becauseperform is
labile anddetermination ofHU of
wasperformed before each comparative ex-
periment (see Materials and Methods) .
Hemolys
P/perforin on RBC from different
species . PFP-containing fractions ob-
tained from rat spleen LAK cells were
tested against the 10 indicated species
ofRBC . No lysis was obtained for cow,
goat, and sheep RBC .6
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"Rat
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" Man
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FIGURE 5. Hemolysis mediated by human
PFP/perforin on RBC from different species.
PFP-containing fractions were prepared from
humanperipheral bloodNK cells that hadbeen
stimulated with 1,000 U/ml ofrIL-2 for 4d (see
Materials and Methods). The different species
of RBC used as target cells are indicated in the
figure. No lysis wasobtained forcow, goat, sheep,
and swine RBC.
coated with mouseanti Thy-1.2 antibodies. EL-4 cellswere lysed by rabbit and guinea
pig C, but not by mouse C (Fig. 6 A). However, EL-4 cells were efficiently lysed
by mouse perforin (Fig. 6 B).
To further investigate the sensitivity of nucleated targets of different species to
lysis by perforin, we challenged cell lines of either murine or human origin with
mouse perforin. Fig. 7 illustrates representative resultsfortwo cell lines, human K562
and murine WEHI-164 tumorcells. Both cell lines were equally susceptible to either
mouse or human perforin. To date, a panel of 15 tumor cell lines ofhuman, simian,
or murine origin hasbeen tested with mouse perforin; no discernible patternof species-
related restriction has been detected (data not shown).
In contrast to the tumor cell lines tested, mouse CTLL were markedly resistant,
whereashuman IL-2-activated NK cells were relatively resistant to both humanand
mouse perforin used in equivalent amounts (Fig. 7, data shown only for CTLL-
R8). Similar results were obtained with CTLL-1 (not shown). We next studied the
response of CTLL to C-mediated lysis. Fig. 8 illustrates representative results ob-
tained with CTLL-R8. CTLL-R8cells, coated with anti-CTLL-R8 cell antibodies,
were incubated with mouse, rabbit, or guinea pig sera as a source of C. As shown
in Fig. 8, both rabbit and guinea pig C lysed R8 cells effectively, but murine C did
not lyse R8 cellseven at the highest serumconcentrations tested (1 :10). These results
show that although homologous species restriction protects CTL effectively against
lysis mediated by C, the same mechanism does not appear to be responsible forpro-
0
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￿
PFP (HU)
n
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FIGURE6.
￿
C- andPFP/perforin-induced)ysis
of EL-4 cells. This was determined in 51Cr
release assays using "Cr-labeled EL-4 cells
(A) coated with antiThy-1.2 mAb and in-
cubated with the indicated dilutionsofguinea
pig (O), rabbit ("), and mouse (A) sera for
1 h at 370C or (B) incubated with mouse-
purified PFP/perforin (O) for 3 h at 37'C.testingCTL against perform-mediated injury,
both homologous and heterologous perform.
Human LAK cells derived from primary cultures were only partially resistant
to both mouse andhuman perform (Fig. 7) . However, the extent of their resistance
was comparable regardless of whether marine or human perform was use
7) . These cells were consistently more resistant than human T and B lymphocyte
subsets (not shown) . The resistance ofhuman LAK cells to either form of perform
varied directly with theduration of IL-2 stimulation(Liu, unpublished observations).
Sensitivity ofPrimary Cells to C- andPerform-mediated Lysis.
￿
Thymocytes freshlyob-
tained from CD2Fi mice were coated with antiThy-1.2 antibodies and treated with
C from different species (Fig . 9). Thymocytes treated this way were lysed effectively
by both rabbit and guinea pig C, but not by mouse C (Fig. 9 A) . However, both
mouse and rat perform lysed the mouse thymocytes equally well (Fig. 9 B) .
is structurally relatedto the terminal components ofC(16-19),
it is reasonable to hypothesize that the mechanisms by which cells are protected against
thetwoformsofcytolysis may be related or identical. Moreover, since isolated human
C8BP/HRF incorporated into SRBC were shown to protect these cells from lysis
both by human C and by human perform, suggestions were made that HRF may
be active also in protecting lymphocytes from lysis induced by either lytic mediator
(27, 28) . HRF is thoughtto be structurally related toC8and C9 (10), andby analogy,
HRFmay be homologous to perform. By complexing rapi
0
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1 :40
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1:20
Dilution of Sera
-M
11sis ofnucleated cells mediated by marine
PFP/perforin . Marine PFP was obtained
PFP, obtained from IL-
ated NK cells, was that used in Fig . 5. 5'Cr-
8, K362, and Wehi-164 cells in log phase
cral blood LAK cells (see Materials and
were used as targets. 12 .5HU ofmarine and
P each were used . "Cr release was deter-
mined after a 3-h incubation at 37'C,
to
FIGURE 8.
￿
Susceptibility ofCTLL to
mologous and heterologous, C. 51Cr-labeled, anti-
R8 antibodies-coated CTLL-R8 cells (see Materials
andMethods) wereincubated with guineapig, rabbit,
and mouse sera at the indicated dilutions for I h at
370C before 5lCr release determination .JIANG ET AL.
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Cytolysis of primary cells by C
and PFP/perforin: comparative analysis. (A)
Thymocytes from CD2F, mice were 5iCr-
labeled andcoated with antiThy-1.2 mAb as
described (see Materials and Methods). 5'Cr
releasewastested afterincubation (3 h, 37°C)
of the cells with the indicated dilutions of
guinea pig ("), rabbit (O), and mouse (A)
sera for 3 h at 37°C. Triplicate samplesof 2
10~ cells were used per data point. (B) 5iCr-
labeled mouse thymocytes were incubated
with mousepurified PFP/perforin (O) andrat
PFP-containing fractions (").
with attacking C8 and C9 molecules, HRF is thought to interrupt the C polymer-
ization process that leads to channel formation.
Here, we report a detailed comparative analysis on the characteristics of C- and
perforin-mediated lysis of several types of cells from different species. Our results
indicate that not only RBC, as previously described by other investigators (20-23),
but also nucleated target cells, including primary and long-term culture cells, are
resistant to lysis by homologous, but not heterologous, C. These data support the
notion of homologous species restriction for C-mediated lysis, extendinga previous
observation to indicate that HRF is present on a wide variety of cell types. In fact,
C8BP-HRF hasbeen identified in human RBC and some nucleated cells, including
human polymorphonuclear leukocytes, Raji cells, and large granular lymphocytes
(10, 24-28). HRFmediated protection is, thus, likely to have a role in sparing the
host from developing injuries in response to circulating autoantibodies or otherinflam-
matory factors that otherwise activate autologous C.
We show here that, unlike C, perforin preparations obtained from three different
species are all capable of target cell lysis across a variety of species, including cell
types that are resistant to homologous C, such as RBC and nucleated long-term
and primary target cells. Only RBC from cow, goat, sheep, and swine, of all species
tested, are insensitive to rat or human perforin, although they are sensitiveto mouse
perforin.
Because, as shown here, no correlation is demonstrable betweenprotection oftargets
against C- and PFP-mediated cytolysis and because susceptibility of target cells to
perforin is independent from the species oforigin of perforin used, ourdata indicate
that the phenomenon ofhomologous species restriction does not operate in perforin-
induced lysis of either RBC or nucleated, noncytotoxic, target cells. Based on these
observations, we conclude that the resistance of cells (including cytolysic lympho-
cytes) to perforin-inflicted injury can not be mediated by C8BP/HRF. If HRF were
themolecule responsible forprotection oflymphocytesandothercells against perforin-
mediated killing, then it would be difficult to explain why perforin lyses HRFcon-
taining target cells. We cannot, however, rule out the possibility that HRF may have
some affinity for perforin and that, at high concentrations, such as in the case of
reconstitution experiments performed by Zalman et al. (27), it may exert some pro-
tective function against perforin-mediated lysis.
CTL and NK cells to date have been shown to be the only cell types resistant2216 CYTOLYTIC LYMPHOCYTES RESIST PERFORIN-MEDIATED KILLING
to perforin-dependent lysis (11-15). Although mouse CTL lines have been shown
to be sensitive to heterologous C but not to perforin (11, 13), the role of HRF in
mediatingresistance ofCTL to perforin was not addressed in those initial studies.
Our data support the possibility that CTL carry HRF on their surface, since these
cells are protected from homologous but not heterologous C. However, the observa-
tion that CTL are equally resistant to perforin from different species further sup-
ports our conclusion that the protective mechanism(s) ofthese cells is not species
restricted, as in the case ofC-mediated lysis, and that distinct mechanisms are in-
volved in protection ofcytotoxic cells against C- and perforin-mediated lysis. Our
studies indicate that primary LAK/NK cell cultures, like CTL, are also partially
resistant toperforin. Preliminary studies showthat theresistance ofNK cellsto per-
forinisacquiredand inducible byIL-2 (Liu, unpublishedobservations). We noticed
that primary LAK/NK cells are relatively resistant to perforin attack when com-
pared with B and T cell subsets. However, these cells are less resistant to perforin
than mouse CTLL grown in long-term cultures in the presence ofIL-2, suggesting
the possibility that, in long-term cultures, cytotoxic cells may have been selected
continuously for the perforin-resistant phenotype.
At the moment, itisdifficult to explain why some species ofRBC tested are resis-
tant to the rat and human forms ofperforin while being susceptible to mouse per-
forin. SRBC are amongthe resistant cells. These dataarein agreementwithaprevious
report (41) in which we were unable to detect measurable lysis ofSRBC using NK
cell extracts containing human perforin, asdetected biochemicallyand on thebasis
ofits ability to insert channels in lipid bilayers, and with that ofZalman et al. (27)
showing that a human form ofPFP/perforin induced only weak lysis ofSRBC after
a 5-h incubation at 37°C. The observation that RBC from four species are insensi-
to lysis by rat and human perforin only is difficult to explain at the moment
but is important to be kept in mind when interpreting data obtained using only
hemolysis totestforthe presence ofPFP/perforin in cell types from different species.
This cautions us to choose appropriate RBC targets for experimental studies of
perforin.
The nature of the self-protective mechanism(s) of cytolysic lymphocytes is un-
known. Our observations do not rule out, for example, the possibility that a mole-
cule (protectin?) closelyrelated tobutnot identical to HRF is involved in protecting
lymphocytes from perforin-mediated damage. On the other hand, since lympho-
cytes may deploy multiple pathways of target cell damage, it is also possible that
multiple mechanisms (andpolypeptides)are involved inmediatingprotection oflym-
phocytes against self-inflicted injury. Further experiments arewarranted to substan-
tiate these and any other speculations.
Summary
CTL and NKcellsresist self-mediatedkilling and lysisby theirownpore-forming
protein (PFP; perforin). Perforin, like C, lyses RBC. Efficient C-mediated lysis of
RBC occurs when both C and RBC are from different species (homologous species
restriction). Aprotective surface protein (C8-binding protein, homologous restric-
factor) has been reported to mediate both homologous species restriction in
C-dependent cytolysisand protection ofsometarget cellsagainstperforin-induced lysis.
We show here thatperforin, unlike C, lyses target cells across avariety ofspecies,including the homologous one, while the same target cell populations resist the at-
tack by homologous C. Perforin-containing extracts of CTL and LAK/NK cells from
three species (rat, mouse, and human) and purified mouse perforin were tested against
RBC from 10 different species, several nucleated target cell lines, and one primary
cell population (thymocytes). While resisting lysis by homologous C, most of these
cell types were lysed effectively by perforin without any homologous restriction pat-
tern. CTL and NK cells, like other nucleated targets, are resistant to lysis by homol-
ogous but not heterologous C ; however, these cell types are resistant to both homolo-
gous and heterologous perforin. Together, our results suggest that the protective
mechanisms associated with C- and perforin-mediated lysis are distinct.
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